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Abstract 
 
Background: Dementia is a progressive neurodegenerative life-limiting disease. The 
international literature indicates that patients with advanced dementia may benefit from 
palliative care provided during the end of life phase. However, evidence indicates that 
currently many fail to access such provision despite the increased recognition of their 
palliative needs. Aim: To investigate the factors influencing provision of palliative care 
services for people with advanced dementia. Method: A systematic review of mixed 
method studies written in English was undertaken. 11 electronic databases including 
Embase, Medline, PubMed, CINHAL and Scopus from 2008 to 2018 were searched. 
Narrative synthesis and content analysis were used to analyse and synthesise the data.  
Key findings: In total, 34 studies were included. 25 studies providing qualitative data, 6 
providing quantitative data and 3 mixed methods studies. The findings identified 
organisational, healthcare professionals and patients related barriers and facilitators in 
provision of palliative care for people with advanced dementia from perspective of 
stakeholders across different care settings. The most commonly reported barriers are 
lack of skills and training opportunities of the staff specific to palliative care in dementia, 
lack of awareness that dementia is a terminal illness and a palliative condition, pain and 
symptoms assessment/management difficulties, discontinuity of care for patients with 
dementia and lack of co-ordination across care settings, difficulty communicating with 
the patient and the lack of advance care planning. Conclusions: Even though the 
provision of palliative care was empirically recognised as a care step in the 
management of dementia, there are barriers that hinder access of dementia patients to 
appropriate facilities. With dementia prevalence rising and no cure on the horizon, it is 
crucial that health and social care regulatory bodies integrate a palliative approach into 
their care using the identified facilitators to achieve optimal and effective palliative care 
in this population. 
 
Key words: Advanced Dementia, Palliative Care, End of Life Care, Barriers, 
Facilitators. 
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1. Introduction  
 
Dementia is a general term used to describe a group of progressive neurodegenerative 
syndromes in which there is cognitive deterioration leading to decline in memory, 
judgement, and learning as well as orientation impairment and behavioural changes 
interfering with the activities of daily living [1]. The clinical symptoms associated with 
dementia can be divided into three stages: early, middle and advanced stage [2]. The 
focus of this research is on the end stage dementia. 
 
The prevalence of dementia is expanding rapidly and currently reaching around 50 million 
people worldwide [1]. The incidence of dementia is estimated to be over 9.9 million new 
cases per year worldwide, making dementia a global public health priority [1,3,4]. The 
number of people living with dementia varies from one region to another with the majority 
of cases i.e. 58% distributed around the low and middle-income countries (LMIC), which is 
projected to increase more rapidly in comparison to the high-income countries [4].  
 
Advanced dementia is the stage of profound cognitive and physical impairment [2, 5]. It is 
characterised by dysphagia, incapability to communicate and severe memory decline [2]. 
The late stage of dementia is one of the main causes of disability and it account for 11.9% 
of the years lived with disability (YLD) and it is considered the primary reason of 
dependency and disability among the aging population [6]. A retrospective study 
concluded that people with advanced dementia experience similar symptoms and have 
equivalent healthcare needs similar to other terminal diseases such as cancer [7]. Thus, 
recognising advanced dementia as a terminal condition with the end of life care needs [8, 
9].  
 
The WHO has defined Palliative Care (PC) as “an approach that improves the quality of 
life of patients and their families facing the problems associated with life-threatening 
illness, through the prevention and treatment of pain and other problems, physical, 
psychosocial and spiritual” [10]. The same principles apply to end of life care (EoLC) in 
advanced dementia as defined by the European Association of Palliative Care (EAPC) 
[11].  
 
 
 
The World Palliative Care Alliance (WPCA) and the WHO have recognised advanced 
dementia as a life-limiting condition and as a disease that requires PC at the end of life 
stage [12]. However, despite their efforts, the WHO does acknowledge that palliative 
needs of people with dementia are often unmet, under-assessed and under-treated in 
some regions [13]. Recent studies have suggested that a PC approach can be beneficial 
for patients with advanced dementia but the implementation process still presents unique 
challenges [14]. 
 
Several studies have explored the barriers associated with the provision of effective PC for 
dementia patients [15,16]. One of the main challenges is that despite the progressive 
nature of dementia, it is under-recognised as a terminal illness in some regions [17]. 
Additionally, even though there is a gradual decline in both cognitive and physical abilities, 
there are no abrupt health changes that can be used to clearly identify the terminal phase 
of dementia unlike cancer trajectory [18]. Furthermore, the communication difficulties 
experienced in the late stage of dementia, makes the delivery of care difficult and creates 
additional barriers to effective provision of PC [15]. Moreover, many studies indicated that 
healthcare providers have a vital role to play in transition of patients with dementia to PC 
services, but they are reluctant to do so [19, 20]. This could be due to ethical debates and 
differing views about extending the life of dementia patients [19, 20]. Finally, lack of care 
pathways and clinical guidelines on PC specific to dementia poses several dilemmas to 
the provision of optimal EoLC in this population [14]. Both of the Liverpool Care Pathway 
(LCP) and the Gold Standards Framework (GSF) are being used in the management of 
EoLC in dementia, which facilitates the delivery of PC in a range of care setting [21].  
 
 
There has been an increased interest worldwide on extending PC services to include 
people with dementia [11]. Yet, the evidence suggests that many nations still have a long 
way to go in providing effective PC to people with advanced dementia. Therefore, the aim 
of this systematic literature review is to investigate the factors influencing the provision of 
PC services for people with advanced dementia through the following objectives: 
 
• To investigate whether palliative care is empirically recognised as a care step in the 
management of patients with advanced dementia.  
   
 
 
• To establish the barriers and enablers to provide end of life care for people with 
advanced dementia from the stakeholders’ perspective (i.e. patients, carers, 
healthcare professionals, healthcare commissioners/policy experts and 
manager/directors). A healthcare commissioner is defined as a member of the 
healthcare system that oversees the process of purchasing and monitoring 
healthcare services to improve health outcomes [22]. 
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Methods  
 
A systematic review of mixed method studies of primary articles was conducted according 
to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines [23]. The search question was addressed using empirical evidence and the 
studies were included based on a predefined inclusion and exclusion criteria.  
 
Search strategy: 
  
11 electronic databases were used to search for primary articles that addressed PC for 
people with dementia. These were: Embase + Embase Classic; Ovid Medline; All The 
British Library subscribed journals; Health and Psychological Instrument; Health 
Management Information Consortium (HMIC); PsycEXTRA; PsycINFO; International 
Pharmaceutical Abstract; PubMed; CINHAL and Scopus. The reference lists of the 
included studies were scanned to identify additional relevant articles. A string for PubMed 
is outlined in Table 1. Using dementia as a MeSH term or searching specific alternatives 
terms of dementia, which included its different causes (e.g. vascular dementia, dementia 
with Lewy bodies and frontotemporal dementia, generated similar results. Therefore, 
dementia was used in all the subsequent searches. The search was limited to articles in 
English due to lack of resource for translation. Followings were excluded: grey literature, 
conference abstracts, literature reviews, editorials, correspondence, commentaries and 
protocol studies due to lack of time. The search was completed by the end of July 2018.  
 
 
 
 
 
 
Inclusion and exclusion criteria  
 
All primary research articles including qualitative, quantitative and mixed method reporting 
barriers and/or facilitators in provision of PC in advanced dementia in all care settings 
worldwide were included.  A 10-year timeframe from 2008 to 2018 was selected. The 
reason for choosing 2008 as the starting point was based on due to publication of the End 
of Life Care clinical practice guideline by the Department of Health [24], which for the first 
time promoted PC in dementia patients.  This was followed by a flurry of studies focusing 
on dementia covering mild to moderate as well as advanced stages.  This review only 
includes the advanced stage studies that are relevant for the end of life palliative services 
of dementia. This was done during title and abstract screening stage as well as full text 
screening process. Moreover, all the articles that did not discuss the barriers or the 
facilitators to the provision of PC in advanced dementia were excluded along with studies 
that evaluated the effectiveness of a specific facilitator approach/tool to the provision of PC 
in dementia.  
 
Study selection  
 
The process of the study selection is detailed in the PRISMA flow diagram [23] as can be 
seen in Figure.1. After merging results obtained through databases and manual searches, 
a total 1932 studies were noted, which went down to 1511 after duplicates were removed. 
The titles and abstracts of the remaining articles were then screened to identify potentially 
“Dementia” OR “Advanced Dementia” OR “End Stage Dementia” OR “Alzheimer’s” 
AND 
 
“Palliative Care”[Mesh] OR “Palliative Medicine”[Mesh] OR “Palliative Services” OR “Palliative 
Interventions” OR “Palliative” OR “Terminal Care”[Mesh] OR “Hospices”[Mesh] OR “End of Life Care” OR 
“Hospice Care” 
AND 
 
“Barriers” OR “Facilitators” OR “Factors” OR “Enablers” OR “Issues” OR “Challenges” OR “Contributors” 
Table 1: Search Strategy of PubMed 
 
 
relevant studies using EndNote software [25]. 1428 articles were excluded based on the 
title and abstract screening. Afterwards, the full text article of the remaining 83 potential 
studies was obtained except for one (poster abstract). The full text articles were reviewed 
and assessed comprehensively against the inclusion and exclusion criteria, which resulted 
in the exclusion of 49 articles. Initially, one reviewer (MM) conducted the search and 
screened titles/abstracts. To check the validity a second researcher reviewed and 
assessed the papers against the same criteria. An academic clinician acted as a referee in 
case of any disagreement between the findings of the two-initial reviewer. 
 
Data Extraction  
 
The following information was extracted for each included study using Excel [26]: (1) aim 
of the study (2) the method used, method of analysis and study design (quantitative, 
qualitative, or mixed methods) (3) the country (4) the setting (care homes, hospitals, 
hospice care facilities, Specialists palliative care service, general practices, residential 
care homes, memory clinics, commissioning services, community setting, NHS continuing 
care units, adult services, specialist Elderly Mentally Infirm (EMI) homes, intellectual 
disability services, group living homes, adult day-care, nursing homes, mental health trust, 
assisted living residents, and patient’s home) (5) the sample size (6) whether or not PC 
was recognised as management step in advanced dementia and (7) The barriers and 
facilitators for provision of PC in this population. The results were extracted with a focus on 
the research question, aim and objectives. Data for the narrative synthesis and content 
analysis were only extracted from the result section of papers to maintain a degree of 
credibility. 
 
Data synthesis and analysis 
 
A narrative synthesis was conducted, drawing on the framework and techniques described 
in “Cochrane Consumers and Communication Review Group on Conducting Narrative 
Synthesis” [27]. The first step taken was developing a preliminary synthesis of the finding 
of the studies. Also, similar features of studies were summarised and grouped. The results 
were tabulated to identify patterns and emerging themes across the studies.  All the data 
were then transformed into descriptive format. The data were coded and the frequencies 
of codes were identified. The theme appearing in more than one paper demonstrates a 
degree of validity. Therefore, the number of studies within a specific theme was reported in 
 
 
this review. Finally, content analysis was conducted to identify commonality as well as 
differences among included studies. One reviewer (MM) conducted the data synthesis and 
analysis.  The final themes were achieved through discussion and agreement of both 
authors (MM and ZA). Through all the stages of the review 25% of the sample was 
checked by the second author to ensure reliability of the data.  
 
Quality assessment 
  
In this systematic review, as there’s a combination of quantitative, qualitative and mixed 
methods studies, the Mixed Methods Appraisal Tool (MMAT) was used as it allows 
assessing studies of various designs [28]. It is a validated tool developed at McGill 
University which comprises of a total of 19 methodological quality criteria for appraising 
quantitative (4 criteria for Randomised Controlled Trials (RCT), 4 criteria for Non-RCT and 
4 criteria for descriptive quantitative), 4 criteria for qualitative and 3 criteria for mixed 
methods studies, which are scored on a nominal scale (Yes/No/Can't tell) [28]. Therefore, 
for both quantitative and qualitative studies the maximum score is 4 out 4, while for mixed 
methods studies the maximum score is 11 which is calculated through adding the score of 
the quantitative component with the score of qualitative component as well as the score for 
mixed methods studies [28].  
 
Ethical issues 
This is a secondary research, which means there are no participants involved and it was 
not subject to an ethical approval process. 
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Results 
 
Description of included studies 
 
A total of 34 studies [29-62] were included in the review (see Figure 1), with 25 studies 
providing qualitative data, 6 providing quantitative data and 3 mixed methods studies. 
Details related to the study characteristics are provided in the online supplementary file. 
The studies varied widely on a number of characteristics including country, setting and 
participants. Studies providing quantitative data tended to measure the barriers and 
facilitators of the provision of PC using questionnaires and cross sectional postal surveys. 
The qualitative studies measured the barriers and facilitators using semi-structured 
interviews, in-depth interviews, focus groups and participant observation. The 3 mixed 
methods studies used questionnaires/ semi-structured interviews, interviews and focus 
groups/ case note audit and economic data and telephone/online survey.  
 
Country, setting and participants  
 
The studies were conducted in several countries as can be seen in the supplementary file 
online including the United Kingdom, England, United States, Canada, Ireland, 
Netherlands, Belgium, Norway, Italy, Germany and Australia, all of which are high-income 
countries with the majority having taken place in the United Kingdom specifically England 
[4]. None of the studies were undertaken in a low and middle-income country. Data were 
mostly derived from care homes, hospitals, hospice care facilities, Specialists PC service, 
general practices and residential care homes (See supplementary file online). Out of all 
the studies, 29 derived data from healthcare professionals/providers [30-38, 40-53, 55- 57, 
59, 60, 62], 11 from managers/directors of care facilities [34-36, 43, 44, 46, 47, 52, 57, 60, 
61], nine studies from carers/caregivers [29, 38, 42, 45, 54, 56-59], one study from the 
patient’s perspective [54] and seven focused on the commissioner’s and policy expert’s 
perspectives [35, 36, 39, 43, 44, 46, 56]. See also barriers to provision of PC from different 
stakeholders’ perspectives in the online supplementary file for further details. 
 
 
 
 Barriers Affecting the Provision of Palliative Care in Advanced Dementia 
Patient/carers 
Related Factors 
Condition Related 
Factors 
Policy 
Related 
Factors 
Healthcare 
System 
Related 
Factors 
Healthcare 
Team Related 
Factors 
Therapy 
Related 
Factors 
Attitude-
awareness and 
beliefs Related 
Factors Lack of ACP (11)  [32, 38, 40, 42, 43, 45, 48-50, 54, 56] Pain and symptoms assessment. (12)  [34, 37, 42, 44, 45, 
49-51, 55, 58, 59]  
Medicare 
hospice 
eligibility 
criteria and 
requirement. 
(4) 
[35, 52, 60, 
62] 
Discontinuity 
of care and 
lack of co-
ordination 
across care 
settings. (12) 
[32, 35, 36, 
40, 43, 44, 46, 
49, 51, 54, 55]  
Lack of skills 
and training 
opportunities 
specific to PC 
in dementia. 
(17) 
[31, 32, 34-36, 
38, 41-44, 49-
51, 54-56, 61] 
Lack of 
access to PC 
specialist 
support (5) 
 
[31, 32, 49, 
55, 56] 
Lack of 
awareness that 
dementia is a 
terminal/palliative 
condition. (12) 
 
[29, 31, 32, 40, 
41, 44, 52-55, 
59] Communication difficulties between HCP and carers (7) [32, 35, 41, 42, 52, 55, 59]  
Difficulty 
communicating with 
the patient. (11) 
[35, 40-42, 44, 45, 
49, 51, 52, 55, 57] 
Reimbursem
ent Policies:  
Inadequate 
providers, 
difficult 
process. (3) 
[35, 60, 61] 
Lack of funds 
and limited 
availability of 
resources. (9) 
[32, 35, 39, 
41, 43, 46, 54, 
55, 57] 
Lack of 
knowledge and 
education of 
dementia. (8) 
[31, 32, 41, 42, 
44, 45, 49, 51] 
Lack of 
knowledge 
about PC in 
dementia. (4) 
[31, 34, 35 
41] 
Negotiation of 
risk; fear of legal 
consequences 
and blame. (4) 
[36, 38, 44, 48] 
Lack of provision of the condition’s necessary information (prognosis and future expectations) to carers/caregivers (5)  [32, 38, 41, 42, 59] 
Uncertainty 
identifying the 
terminal stage of 
dementia and 
difficulty initiation 
palliative therapy due 
to the unpredictable 
trajectory/prognosis. 
(9) 
[32, 33, 35, 38, 40, 
41, 44, 47, 52] 
Lack of 
commissioni
ng guidance 
on dementia 
[39].  
Lack of 
integration 
between 
services. (3) 
[35, 39, 49] 
Lack of 
communication 
between 
services, HCPs 
and care 
settings. (8) 
 
[32, 35, 41, 43, 
52, 57, 59]  
 
 
Lack of 
standardised 
clinical 
guidelines/pro
tocols and 
information. 
(4) 
 
 
[32, 36, 40, 
41] 
Lack of 
awareness and 
beliefs in ACP 
(4)   
 
[44, 45, 48, 56] 
Family resistance and disagreement/conflicts over decision-making. (4) [32, 34, 41, 55]  
Behavioural 
symptoms (BPSD). 
(8)  
[34, 42, 44, 52, 55, 
56, 61] 
 
Lack of key 
policy drivers 
in regard to 
advanced 
dementia 
care [43]. 
Lack of ACP 
discussions 
within primary 
and secondary 
care (3) 
 
[42, 43, 45] 
Unnecessary 
hospitalisation: 
impact of 
hospitalisation. 
(8) 
[32, 38, 42, 46, 
49, 51, 52, 56] 
 The use of PC is 
not considered 
meaningful in 
dementia. (3) 
 
[30, 35, 53] Lack of respite services. (2) [32, 61]  
Dysphagia 
(swallowing 
difficulties). (3) 
[34, 45, 50] 
 
The 
presence of 
regulations 
and 
government’
s policy 
promoting 
fragmented 
care [43]. 
Services are 
driven via 
business 
model of care; 
driven by profit 
rather than 
optimal care. 
(2) [43, 44]  
Low staff levels 
(8) 
[38, 39, 41, 43, 
44, 46, 50, 57] 
 Lack of 
awareness of 
hospice 
availability/ PC to 
Advanced 
dementia (2) [52, 
61] 
Financial burden (2) [52, 56].  Difficulty maintaining adequate nutrition 
and hydration. (3) 
 [49-51]. 
The use of 
Medicare 
skilled 
nursing 
facility 
benefit [60] 
 
Lack of clear 
integrated 
dementia care 
pathways: 
Specifically in 
acute 
hospitals [56].  
Poor 
interdisciplinar
y approach; 
between 
different HCPs, 
services and 
settings. (5) 
[32, 43, 55, 59, 
61]  
 Societal attitudes 
towards older 
people 
(undervalued) 
[43]. 
   Difficulty 
accessing 
healthcare 
funds [54]. 
 
High levels of 
staff turnover. 
(5)  
[38, 41, 43, 44, 
46] 
 Unfamiliarity with 
hospice 
admission 
criteria [62].     Time 
Constraints. (4) 
[32, 35, 41, 57] 
 Dementia is not 
considered 
worthy of PC 
[55]. 
    Lack of 
consistency at 
workplace [43]. 
  
Table 2: Barriers of the provision of palliative care in advanced dementia  
 
 
 
 
 
 
 
 
 
 
Facilitators enabling the Provision of Palliative Care in Advanced Dementia 
Patient Related 
Factors 
Condition 
Related Factors 
Policy 
Related 
Factors 
Healthcare 
System 
Related 
Factors 
Healthcare Team 
Related Factors 
Therapy 
Related Factors  
Attitude-
awareness 
and beliefs  Advance directives and care planning (12)  [33, 34, 40-42, 44, 45, 47-49, 51, 60] 
Provision of 
accurate 
prognosis 
algorithms:  FAST 
terminality criteria. 
(2) [32, 52] 
 
Medicare 
benefits for 
advanced 
dementia 
[52].  
Ensure 
continuity of 
care through 
integration of 
services. (3) 
[44, 46, 47] 
 Multidisciplinary 
approach; between 
HCPs, services and 
settings:  
Collaboration with 
PC teams/hospice 
and access to PC 
specialists support. 
(11) [32, 33, 36, 41, 
45-47, 49, 51, 55, 61] 
 
Incorporation 
and 
implementation 
of the GSF and 
LCP into 
practice. (6) 
 
[36, 38, 45-47, 
56] 
Increase 
awareness of 
the public and 
family 
specifically 
about the dying 
process, the 
nature of 
dementia and 
services 
provided. (3) 
[40, 41, 47] Educating family members and carers on the prognosis of dementia and future expectations. (3) [40, 41, 47] 
Guidelines/ 
protocols and 
Care pathways. 
(3) 
 
[32, 33, 40]  
UK Mental 
Capacity 
Act and the 
best 
interest 
approach 
[55] 
Allocate funds 
and resources. 
(2) 
 
[32, 41] 
Additional training 
specific to PC in 
dementia (End-of-
Life dementia care)  
(10) 
[32, 33, 41, 45, 47, 
51, 54, 55, 56] 
Community 
Matrons 
Services [38].   
Increase 
awareness 
about ACP 
[42].   
Effective communication skills when dealing with family members (3)  [42, 47, 57] 
Pain assessment 
tools and scales 
[60].   
 The 
development 
of multi agency 
dementia care 
pathway [56].  
Enhanced Education 
(3) 
[32, 40, 41].  
 
  
Emergency healthcare plans (DNACPR) [47].    Non-pharmacological interventions to 
manage BPSD or 
antipsychotics  
[60]. 
 Cost effective 
PC 
interventions in 
the community 
[56].  
Avoiding any 
unnecessary 
hospitalization  (2) 
[44, 47] 
  
   Publicising of 
carer support 
services like 
Admiral Nurse 
Service and 
Memory Clinic 
[56]. 
Effective 
communication 
between HCPs [57].  
  
    Spending more time 
with dementia 
patients [41]. 
  
    Advance directives 
tools such as “Five 
wishes”/ Advance 
directives forms [60].  
  
    Building relationships 
with the patients and 
their families [57]. 
  
Table 3: Facilitators of the provision of palliative care in advanced dementia 
 
 
Quality ratings 
 
As mentioned above, the Mixed Methods Appraisal Tool (MMAT) was used to carry out the 
quality assessments of the studies. Quality ratings of qualitative and quantitative studies 
ranged from 2 to 4 and corresponding ratings from mixed methods studies ranged from 8 
to 9 (out of 11) (See supplementary file online). However, one study of the mixed methods 
design was rated out of 10 instead of 11 as the quantitative method used looked at case 
note audit and the criteria assessing the response rate wasn’t applicable [56]. Research 
questions, study design, sample size and participant/setting selection were mostly well 
described for all the data; whereas methods of data collection, analysis and reporting of 
findings were areas of weakness across lower quality studies. However, none of the 
studies were excluded on the basis of its quality.  
 
Data synthesis and analysis  
 
Narrative synthesis and content analysis first answered whether or not PC is empirically 
recognised as a care step in the management of patients with advanced dementia. In 
identifying barriers and facilitators for provision of PC in advanced dementia seven main 
themes emerged (Table 2 and 3).  Furthermore, all interconnected 46 subthemes for the 
barriers and 27 subthemes for the facilitators were extracted. The seven main themes 
were factors related to patient/carers, condition (dementia), policy, healthcare system, 
healthcare team, therapy (PC), and attitude-awareness and beliefs. Fewer facilitators than 
barriers were reported and there was variation in the relative contribution of each study to 
each theme. Additionally, two papers specifically discussed pain management as the main 
barrier for the provision of PC (Table 4). Moreover, the narrative synthesis and content 
analysis further generated eight descriptive themes of the barriers from the perspective of 
patients, carers/caregivers, healthcare professionals/providers; managers/directors of care 
facilities and commissioners/policy experts (See supplementary file online).  
 
Recognition of palliative care as a step in the care of advanced dementia 
 
Out of the 34 studies, 24 studies recognised PC as a management step in the care of 
advanced dementia [31,33,34,36-38,40-47,49-51,56,57,59-62], whereas 7 studies rejected 
 
 
PC as a management step [29,30,32,35,52-55] and 3 of them did not discuss it in their 
research [39,48,58].  
 
Barriers and facilitators for the provision of palliative care in advanced dementia  
 
A. Patient/Carer  
 
The most commonly reported barriers within this theme were the lack of advance care 
planning (ACP) [32, 38, 40, 42, 43, 45, 48-50, 54, 56], communication difficulties between 
healthcare professionals and patient's caregivers [32, 35, 41, 42, 52, 55, 59], the lack of 
provision of information about the condition such as its prognosis and future expectations 
of carers/caregivers [32, 38, 41, 42, 59]. The facilitators included: advance directives/ 
advance care planning [33, 34, 40-42, 44, 45, 47-49, 51, 60] and emergency healthcare 
plans such as Do Not Attempt Cardio-pulmonary Resuscitation (DNACPR) [47]. 
 
B. Condition  
 
This theme relates to the end-stage of dementia and how symptoms as well as cognitive 
and functional impairments of the disease formed several barriers to the provision of PC. 
The most frequently cited barriers were pain and difficulties in symptom 
assessment/management and communication [34, 35, 37, 40-42, 44, 45, 49, 51, 52, 55, 
57-59]. Also mentioned were identification of the terminal phase and initiation of palliative 
therapy due to the disease prognostication [32, 33, 35, 38, 40, 41, 44, 47, 52]. On the 
other hand, facilitators related to advanced dementia were reported in several studies and 
included the provision of accurate prognosis algorithms such as Functional Assessment 
Staging Test (FAST) criteria [32, 52], which could be used to determine the terminal stage 
of dementia and the initiation of EoLC, and the development of care pathways and 
guidelines specific to dementia EoLC [32, 33, 40].  
 
C. Policy  
 
Few studies reported on policy related barriers to the provision of PC in dementia and 
included: lack of commissioning guidance on dementia [39], absence of key policy drivers 
with regard to advanced dementia care [43], the presence of regulations and government’s 
policy promoting minimal and fragmented care [43], the use of Medicare skilled nursing 
 
 
facility benefit [60], Medicare hospice eligibility/admission criteria and requirements and 
reimbursement policies [35, 52, 60-62]. Two studies discussed facilitators in this theme 
[52, 55], one of which suggested Medicare benefits for advanced dementia and the other 
recommended the use of UK Mental Capacity Act [63] and the best interest approach to 
manage conflicts and disagreements over decision-making which were mentioned under 
the patients/carers theme.  
 
D. Healthcare system  
 
Healthcare system related factors reported many organisational barriers such as 
discontinuity of care for patients with dementia and lack of co-ordination across care 
settings, as the most cited barriers [32, 35, 36, 40, 43, 44, 46, 49, 51, 54, 55]. Moreover, 
lack of funds and limited availability of resources [32, 35, 39, 41, 43, 46, 54, 55, 57], lack 
of integration between the social and healthcare systems and lack of organised PC 
approach/system [35, 39, 49] as well as the lack of ACP discussions initiated within 
primary and secondary care [42, 43, 45] dominated most of the reported barriers in this 
theme. Facilitators included allocating funds and resources [32, 41], cost-effective PC 
interventions in the community [56], publicising of carer’s support services like Admiral 
Nurse Service and Memory Clinic [56], ensuring continuity of care through integration of 
health and social care services [44, 46, 47].  
 
E. Healthcare professionals 
 
22 studies identified barriers related to health care professionals (HCPs), with the most 
common one being lack of skills and training opportunities specific to PC in dementia 
(End-of-Life dementia care) [31, 32, 34-36, 38, 41-44, 49-51, 54-56, 61]. Unnecessary 
hospitalisation [32, 38, 42, 46, 49, 51, 52, 56], low staff levels [38, 39, 41, 43, 44, 46, 50, 
57], lack of communication between services, HCPs and care settings [32, 35, 41, 43, 52, 
57, 59] and the lack of knowledge and education of dementia among healthcare 
professionals were also common [31, 32, 41, 42, 44, 45, 49, 51]. Contrasting with the 
previous theme, many studies in this theme reported facilitators such as: enhanced 
education of HCPs [32, 40, 41], effective communication between HCPs [57], advance 
directives tools such as “Five wishes” document/ Advance directives forms [60, 64] to 
promote discussions about EoLC options as well as avoiding and minimising any 
unnecessary hospitalisation [44, 47]. The most frequently cited facilitators were 
 
 
multidisciplinary approach between HCPs, services and settings, collaboration with PC 
teams/hospice and access to specialists support [32, 33, 36, 41, 45-47, 49, 51, 55, 61], as 
well as Additional training specific to PC in dementia [32, 33, 41, 45, 47, 51, 54, 55, 56]. 
 
F. Therapy  
 
This theme relates to palliative/ EoLC in advanced dementia and included three main 
barriers: lack of access to PC specialist support [31, 32, 49, 55, 56], lack of knowledge 
about PC [31, 34, 35 41] and absence of standardised clinical guidelines/protocols and 
information regarding PC initiation and provision in advanced dementia [32, 36, 40, 41]. 
Facilitators for this theme included: incorporation and implementation of the Liverpool Care 
Pathway (LCP) and the Gold Standards Framework (GSF) into practice [36, 38, 45-47, 
56]. 
 
G. Attitude, awareness and beliefs  
 
The last theme discussed in 22 studies is attitude, awareness and beliefs and it 
highlighted how lack of public/HCPs awareness, misperceptions and attitudes could 
obstruct the provision of care. The most cited barrier was the lack of awareness that 
dementia is a terminal/palliative condition [29, 31, 32, 40, 41, 44, 52-55, 59]. Other barriers 
included: lack of awareness of hospice availability to advanced dementia and unfamiliarity 
with hospice admission criteria [52, 61, 62] as well as the lack of awareness and beliefs in 
ACP and fear of legal consequences and blame [36, 38, 44, 45, 48, 56]. Facilitators for 
this theme included: increasing awareness of the public and family regarding the nature of 
dementia and available services [40, 41, 47]. 
 
 
 
 
 
 
 
 
 
 
 
Barriers and facilitators of pain managements in advanced dementia  
Two studies specifically examined the barriers and the facilitators of pain assessment and 
management in advanced dementia.  
 
Table 4: Barriers and facilitators of pain assessment and management. 
 
The most commonly reported challenges in these two studies are inability to diagnose pain 
and uncertainty about pain aetiology due to communication difficulties with the patients 
[37, 58]. Other barriers included: lack of guidance and support, complex prescribing 
approaches and Adverse Drug Events (ADEs) [37, 58]. Moreover, administration of 
medication in people with advance dementia posed several dilemmas, which are 
associated with refusal to take medication, dysphagia, poor gut absorption, nausea and 
vomiting and impaired consciousness [37, 58]. Additionally, one of the two studies 
mentioned the lack of training in specific areas like distinguishing between pain and non-
pain BSPD and managing pain in complex patients [37]. Only one study covered the 
facilitators of pain assessment and management and they included: Using non-verbal cues 
to assess pain, WHO analgesic ladder to aid prescribing decisions, seeking specialists 
input, and further training in managing pain in patients with behavioural challenges [37].  
 
Stakeholder’s perspective 
 
The stakeholders included: patients, carers, healthcare commissioners and policy experts, 
healthcare professionals and manager/directors. Eight descriptive themes were generated 
to categorise the previously mentioned barriers under the perspective of stakeholders (See 
supplementary file online). 
 
 
 
Pain assessment and management [37, 58] 
Barriers  Facilitators 
Inability to diagnose pain and uncertainty about the pain etiology due to difficulty 
communicating with patients. (2) 
Collaboration between different HCPs.  
Lack of guidance and support.  Using non-verbal cues  
Complex prescribing and treatment approaches; overtreatment, poor treatment.  WHO analgesic ladder. 
Side effects and Adverse Drug Events (ADE) Seeking specialists input. 
Route of Administration; refusal to take medication, swallowing difficulties, poor 
gut absorption, nausea and vomiting and impaired consciousness.  
Further training in managing pain in patients with behavioral 
challenges.  
Lack of training in specific areas like distinguishing between pain and non-pain 
BSPD and managing pain in complex patients.  
 
 
 
A. Attitude, awareness and beliefs 
 
Apart from commissioners and policy experts, all other stakeholders didn’t recognise 
dementia as a terminal illness nor a palliative condition. Only HCPs feared the legal 
consequences and blame of looking after these patients. 
 
B. Advance Care Planning (ACP) 
 
Only patients, caregivers and HCPs discussed ACP and its implications on the provision of 
care. Family and caregivers lacked awareness of ACP and perceived the lack of initiation 
ACP discussions within the primary and secondary care as a barrier to the provision of PC 
to their relatives as many of them suffered the consequences of making these decisions 
later on.  
 
C. Communication 
 
Carers perceived the lack of communication between HCPs and other care settings as a 
barrier as well as the lack of provision of necessary information regarding their relative’s 
conditions. HCPs agreed with the carers on these two points stating that lack of the 
caregiver’s knowledge regarding the prognosis of the condition could hinder the process of 
ACP.  
 
D. Skills, training and knowledge in care provision 
 
All participants agreed that lack of skills and training opportunities specific to PC in 
dementia was a main barrier to the provision of PC care in this population. Both carers and 
HCPs identified pain assessment and management as a challenging issue while HCPs 
and manager/directors of PC services agreed that BPSD hindered the provision of care.  
 
E. Pathway of care 
 
Apart from dementia patients, all stakeholders indicated that discontinuity of care for 
patients with dementia and lack of co-ordination across care settings and lack of 
collaboration between different HCPs, services and settings as a barrier to the provision of 
PC in this population. Furthermore, both HCP and managers/directors of care facilities 
 
 
found that the lack of standardised clinical guidelines/protocols was a barrier in delivery of 
PC while commissioners/policy experts perceived that lack of commissioning guidance on 
dementia was adversely affecting to their role and responsibilities.  
 
F. Policy and regulations 
 
All three participants (HCPs, commissioners/policy experts as well as managers/directors 
of care facilities) perceived Medicare hospice eligibility criteria and requirements as main 
barrier to admission of people with advanced dementia to hospice care facilities.  
 
 
G. Funds and resources 
 
HCPs and commissioners/policy experts stated the need for funding and perceived lack of 
funds and limited availability of resources as well as difficulty obtaining financial 
reimbursement as barriers to the provision of PC in advanced dementia. 
Managers/directors of care facilities and several HCPs discussed the lack of respite care 
services available for caregivers while caregivers themselves identified the financial 
burden of PC and the difficulty accessing healthcare funds as a significant problem.  
 
K. Organisational issues 
 
HCPs, managers/directors and commissioners/policy experts perceived the high staff 
turnover due to high workload, low pay, and low job satisfaction as a barrier of the 
provision of care especially in this population. Moreover, managers/directors of care 
facilities and HCPs both agreed that the lack of consistency at work place and low staff 
levels hinders the dynamic of PC.  
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Discussion  
 
The findings from this review are consistent with the literature, which shows significant 
gaps and poor experiences during the end of life phase among this population. To best of 
our knowledge, this review is the first systematic review analysing the perspectives 
stakeholders on the contributory factors influencing the provision of PC in advanced 
dementia. This review has provided an insight into the patient’s journey through the end of 
life stage in dementia drawing on a number of stakeholders from different countries and 
settings. Findings suggest that there are significant barriers preventing the transition of 
people with advanced dementia to a palliative care approach. These barriers exist on 
many levels and can be attributed to cultural, policy, disease and systematic aspects of the 
healthcare infrastructure.  
The findings indicated that 7 studies rejected PC as a management step in advanced 
dementia. The lack of recognition that PC is a vital step in the care of dementia is itself a 
barrier to the provision of PC in this population. Another study confirmed that patients of 
non-cancer diagnosis tend to have lower referral rates to PC services and their 
experiences of care at end of life are poorer due to the lack of awareness and recognition 
of the terminal nature of their conditions [65]. The fact that all participants did not 
recognise dementia as a terminal illness nor a palliative condition, affected the patient’s 
EoLC and prevented this population from accessing PC services. This highlights the level 
of awareness of a terminal illness not only improves the quality of life but also the quality of 
death as it gives the patient control over the future, allowing them to make choices and 
prepare for death [66]. This was emphasised in prospective nationwide survey of bereaved 
family members of advanced cancer patients that measured the impact of awareness of 
terminal illness on quality of death and care decision-making [67].  
 
In addition, lack of access to PC services was identified as a key barrier to the delivery of 
EoLC in this population, which is in line with Alzheimer Society report 2015 citing poor 
access to PC services and hospice care in this population [68]. This can be attributed to 
Medicare skilled nursing facility benefit, Medicare hospice eligibility/admission criteria and 
requirements as well as the reimbursement policies. This reflects a policy deficit in the 
healthcare system structure that needs immediate modification.  
 
 
 
The cognitive and functional impairments of advanced dementia are all deemed to be 
challenges that complicated the provision of EoLC in this population. However, it was 
evident from the perspective of all participants involved that healthcare providers and staff 
lacked the necessary level of skills and training specific to End-of-Life dementia care to 
provide PC for pain assessment and management. Pain assessment has been seen 
challenging in this population and has promoted a number of tools aimed at objective 
measurement. Lichtner et al identified in a systematic review of pain assessment 28 tools 
that could be used in clinical practice for people with advanced dementia [69]. Limited 
exposure to such methods of assessment is noted among the included studies. 
Furthermore, all healthcare participants perceived the absence of standardised clinical 
guidelines/protocols and information regarding PC initiation and provision in advanced 
dementia hindering provision of care. These issues were addressed recently in a 
systematic review assessing the PC content in dementia clinical practice guidelines and 
indicated that EoLC was minimal [70]. This highlights the need for evidence-based 
recommendations and clinical practice guidelines specific to end of life dementia care. 
 
Moreover, the lack of integration between the social and health care systems was another 
key barrier that hindered the patients and carers journey through dementia. Governmental 
authorities must bring together the social and health care systems through integration of 
services and collaboration across different settings in order to ensure continuity of care, 
shared decision making and better healthcare outcomes. Unnecessary hospitalisation in 
this population hindered the provision of PC, which could be attributed to the negative 
impact of hospitalisation on people with advanced dementia. Advanced directives tools 
such as the “Five wishes” document, advanced directives forms and emergency 
healthcare plans (DNACPR) could help promote these discussions about end of life care 
options, facilitate ACP and minimise any unnecessary hospitalisation. A survey exploring 
the impact of the “Five wishes” document in planning ahead in life-limiting illnesses 
concluded that 90% of the participants found the document helpful [71]. Caregivers 
reported noticeable deterioration of the patient’s state whenever they’re admitted to the 
hospital. This was attributed to hospital-acquired infections, worsening of BPSD, and 
bedsores. A national audit measuring the quality of dementia care at acute hospitals 
established that the staff levels, level of training and support, specialist services and 
discharge planning is poor and regarded the overall quality of dementia care at acute 
hospitals as suboptimal [72].  
 
 
 
Implications towards practices 
 
Implications for health and social care regulators, policymakers and commissioner as well 
as senior managers/directors of care facilities: 
 
• Raising awareness through public health campaigns that advance dementia is a 
terminal illness and publicising carers support services such as Admiral Nurse 
Service and Memory Clinic.  
• Involving frontline staff in the development and implementation of training programs. 
• Development of evidence-based recommendations and clinical practice guidelines 
specific to end of life dementia care.  
• Where applicable, policy makers can help provide Medicare’s benefits for advanced 
dementia and modify Medicare hospice eligibility criteria and requirements.  
• Health and social care regulatory bodies can increase cost effective palliative care 
interventions in the community 
 
 
Strengths and Limitations of the systematic review 
 
To the best of our knowledge, it is the first systematic review conducted regarding the 
factors influencing the provision of PC from the perspectives of different stakeholders. The 
systematic review is a mixed studies systematic review, which presents a whole picture 
and will thus have unlimited applicability in many contexts.  
 
The lack of studies that included the patient’s perspective could be considered as a 
limitation of this systematic review. Another limitation could be that all of studies included 
were conducted in high-income countries, thus the generalizability of the findings of this 
review may be difficult. Moreover, the use of plurals in the search terms e.g. barriers, 
excluded articles that listed a singular barrier, which is a major limitation of the research.  
 
 
 
Future research 
 
 
 
All of studies included were conducted in high-income countries, which highlights the need 
for future research to be also conducted in Low and Middle Income Countries. Only one 
study included the patient’s perspective after obtaining their consent in the early stages of 
dementia. This could be carried out in future research in order to obtain patients’ 
perspective.  
 
Conclusions  
 
This is the first systematic review analysing the perspectives stakeholders on the 
contributory factors influencing the provision of PC in advanced dementia. Provision of PC 
was empirically recognised as a care step in the management of dementia, however, there 
are several barriers that hinders the access of dementia patients to the appropriate 
facilities. With the prevalence of dementia rising and no cure on the horizon, it is crucial 
that health and social care regulatory bodies integrate a palliative approach into their care. 
The stakeholders are challenged with the results of this review to implement and use the 
identified facilitators to achieve optimal and effective PC in this population improving the 
lives of patients with dementia and their families and ensure quality and equality in the 
provision of end-of-life care.  
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